{
  "ptid_time": "136_S_0426_2007-06-04",
  "img_path": "/data/qiuhui/data/adni/images/136_S_0426/2007-06-04/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 151,426 mm³, 222.1% above the reference mean. With a Z-score of 6.45 (100.0th percentile), this represents profound enlargement; hippocampal volume measures 6,913 mm³, 0.8% below the reference mean. With a Z-score of -0.07 (47.3th percentile), this represents normal volume ; whole brain volume measures 1,267,580 mm³, 23.2% above the reference mean. With a Z-score of 3.04 (99.9th percentile), this represents profound enlargement; entorhinal cortex volume measures 3,558 mm³, 10.4% below the reference mean. With a Z-score of -0.68 (24.9th percentile), this represents normal volume ; fusiform gyrus volume measures 17,808 mm³, 1.4% below the reference mean. With a Z-score of -0.12 (45.1th percentile), this represents normal volume ; middle temporal gyrus volume measures 22,883 mm³, 13.4% above the reference mean. With a Z-score of 1.20 (88.6th percentile), this represents mild enlargement. ",
  "text_data": "Age is 80.6 years. Gender is Male. Education: 16 years. MMSE: 25.0. Logical Memory: 0.0. APOEε4 alleles: 1.0. Biomarker levels: Amyloid beta: 348.10 pg/mL (moderate reduced); Total tau: 170.80 pg/mL (normal ); Phosphorylated tau: 14.89 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The patient shows profound ventricular enlargement (Z-score 6.45) and whole brain enlargement (Z-score 3.04), which are atypical for typical Alzheimer's pathology but may suggest another neurodegenerative process or hydrocephalus. Hippocampal and entorhinal volumes are within normal limits, and Aβ is moderately reduced, while tau markers are normal. The MMSE of 25 is borderline but not definitively impaired.  \n\n**Diagnosis:** **MCI** (given the borderline MMSE and moderately reduced Aβ, but without clear tauopathy or significant medial temporal atrophy).  \n\n**Confidence:** **Medium** (due to conflicting imaging findings—severe ventricular enlargement without corresponding hippocampal atrophy—and lack of clear tau biomarkers).",
  "timestamp": "2025-07-26T16:01:30.292112"
}